Navigation Links
CBI Announces Partnership With Children's Rare Disease Network and The Global Genes Project
Date:4/28/2011

or 339-298-2262.  

Sponsors and Exhibitors include Centric Health Resources, Siren Interactive, CRN, Cryer Health, MME, Almac and Plexius. For more information on sponsorship opportunities, please email Alexa Moore: alexa.moore@cbinet.com.

About CBI:

A subsidiary of Advanstar Communications, CBI Research, Inc. offers Pharmaceutical and Healthcare conferences that serve senior executives and government officials by providing a unique platform for highly focused content and ideal networking opportunities with senior policy- and decision-makers. CBI events provide you with concrete, real-life examples that you can begin to apply at your organization immediately for significant impact on costs and revenue. For more information, please visit http://www.cbinet.com.

About the Children's Rare Disease Network:

The Children's Rare Disease Network works to educate and connect families, caregivers and stakeholders impacted by rare disease worldwide. CRDN is an online community and collaborative portal that includes resources, disease information and an active blog, RARE Blog. For more information, please visit http://www.crdnetwork.org.

About The Global Genes Project:

The Global Genes Project was developed as a collaborative grassroots campaign to educate and drive greater public awareness about rare disease, build community and support the development of effective therapies and treatments for children within their lifetime. For more information, please visit http://www.globalgenesproject.org.

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.'/>"/>

SOURCE CBI Research, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Sequenom Announces Publication Acceptance of Manuscript From Age-related Macular Degeneration Validation Study
2. China Green Material Technologies, Inc. Announces Change of Auditor to Marcum Bernstein & Pinchuk LLP
3. Talecris Biotherapeutics Announces First Quarter 2011 Results
4. PDL BioPharma Announces First Quarter 2011 Financial Results
5. GeoVax Labs, Inc. Announces First Quarter Financial Results
6. BSI Group America Inc. Announces Specialized Regulatory Training Courses for the Healthcare Industry
7. ThermoGenesis Announces China Customer Implements Cord Blood Products
8. Life Technologies Announces First Quarter 2011 Results
9. MiMedx Group Announces First Quarter 2011 Results
10. Collins Stewart Announces Formation of Healthcare Investment Banking Alliance
11. Harvest Technologies Announces Initial Enrollment in Its REVIVE-1 Trial (REtrograde Vascular Infusion of BMAC to ImproVe Heart FailurE)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... Mass. , July 30, 2014  Decision ... pharmacy and medical directors in the ... drivers of biosimilar market penetration will be the ... organizations (MCOs) and the expected lower cost to ... for biosimilars that meet their pricing expectations in ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 Selexis ... for biologic drug discovery and mammalian cell line development, ... CHO-Mplus Libraries ™ will be presented at the 10th ... being held, September 8 – 10, 2014 at the ... , The following abstract will be presented during ...
(Date:7/30/2014)... Wellesley, MA (PRWEB) July 30, 2014 ... report, Global Markets for Enzymes in Industrial Applications ... to reach to nearly $7.1 billion by 2018, registering ... Maximum growth is estimated to be recorded in the ... the forecast period. , Enzyme technology has influenced almost ...
(Date:7/30/2014)... 2014 Researchers often use microelectronic devices ... such devices can do much more – perhaps ... researchers have looked to patterned assemblies of proteins ... engineering to characterize – and potentially control – ... envisioned to recreate animal and human physiological functions ...
Breaking Biology Technology:Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 2Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 3Selexis SA to Present New Data and a Case Study at IBC’s Cell Line Development and Engineering Conference 2Selexis SA to Present New Data and a Case Study at IBC’s Cell Line Development and Engineering Conference 3Global Market for Industrial Enzymes to Reach Nearly $7.1 Billion by 2018; Detergent Enzyme Market to Record Maximum Growth 2Global Market for Industrial Enzymes to Reach Nearly $7.1 Billion by 2018; Detergent Enzyme Market to Record Maximum Growth 3UMD Researchers Bridge Gap between Microelectronics, Biological Systems 2UMD Researchers Bridge Gap between Microelectronics, Biological Systems 3UMD Researchers Bridge Gap between Microelectronics, Biological Systems 4
... (Amex: UPI ),a medical device company that ... dysfunctions, today reported financial,results for the third quarter of ... the third quarter of fiscal 2009 were $3.4 million ... "As we discussed in conjunction ...
... - Victhom Human Bionics Inc., "Victhom" (TSX:VHB), announced ... Mark approval for its Neurostep(TM) System, the first ... on peripheral nerves. CE Mark represents regulatory approval ... any of the Member States of the European ...
... Pharmaceutical Inc. (Nasdaq: BMRN ) announced today ... BioMarin marketing approval for Naglazyme(R) (galsulfase) for the treatment ... pleased to receive marketing approval for Naglazyme in Brazil ... VI patients in the world," said Stephen Aselage, Senior ...
Cached Biology Technology:Uroplasty Reports Third Quarter Fiscal 2009 Results 2Uroplasty Reports Third Quarter Fiscal 2009 Results 3Uroplasty Reports Third Quarter Fiscal 2009 Results 4Uroplasty Reports Third Quarter Fiscal 2009 Results 5Uroplasty Reports Third Quarter Fiscal 2009 Results 6Uroplasty Reports Third Quarter Fiscal 2009 Results 7Uroplasty Reports Third Quarter Fiscal 2009 Results 8Uroplasty Reports Third Quarter Fiscal 2009 Results 9Uroplasty Reports Third Quarter Fiscal 2009 Results 10Uroplasty Reports Third Quarter Fiscal 2009 Results 11Victhom Human Bionics Receives CE Mark for the Neurostep(TM) System, the World's First Fully Implantable Closed-Loop Neuromodulation Therapy for Treatment of Foot Drop 2Victhom Human Bionics Receives CE Mark for the Neurostep(TM) System, the World's First Fully Implantable Closed-Loop Neuromodulation Therapy for Treatment of Foot Drop 3Naglazyme Approved by Brazil's National Health Surveillance Agency 2Naglazyme Approved by Brazil's National Health Surveillance Agency 3Naglazyme Approved by Brazil's National Health Surveillance Agency 4
(Date:7/30/2014)... across-the-board increase in Impact Factors for its molecular ... Reports (Thomson Reuters, 2014) show that Clinical ... in Biochemistry , Biochemical Society Transactions ... in their Impact Factors. The journals are owned ... Press Limited. , 2014 Impact Factors (2013 Impact ...
(Date:7/30/2014)... Americans make better decisions about what they eat, the ... significant changes to the Nutrition Facts label found on ... in Chemical & Engineering News (C&EN), the ... the suggested updates and the fight that has ... points out that while the Nutrition Facts label has ...
(Date:7/30/2014)... from Bjorn Brembs, professor of neurogenetics at the Institute ... figure allowing readers and reviewers to run the underlying ... important leap forward for scientific publishing, by demonstrating a ... scholarly output. , Figure 3 in fact doesn,t really ... to F1000Research , and the figure is generated ...
Breaking Biology News(10 mins):Across-the-board Impact Factor increases for Portland Press Limited 2F1000Research brings static research figures to life 2
... Chemical products, energy sources, oils, paints, and more from biomass ... thought can be obtained. Aware of this, engineer Mara Gonzlez ... as the most suitable processing techniques and technologies for refining ... organic natural resources and thus substitute them for fossil fuels ...
... This release is available in French ... resources, the National Research Council of Canada, the University ... methane-eating bacteria survive in a highly unique spring located ... Lyle Whyte, McGill University microbiologist explains that the Lost ...
... a question asked by marine scientists from the Gulf of Mexico ... and marine habitat once it has been damaged or even killed? ... may be a cheap and simple solution that can be used ... was carried out by Dr Graham Forrester, from the University of ...
Cached Biology News:Ph.D. thesis opens doors to obtaining chemical products and materials using biomass as raw material 2Ph.D. thesis opens doors to obtaining chemical products and materials using biomass as raw material 3Could life survive on Mars? Yes, expert says 2Coral transplantation the simple and cheap solution to reef restoration 2
Goat polyclonal to PINX1 ( Abpromise for all tested applications). entrezGeneID: 54984 SwissProtID: Q548A5...
... membrane-filtered isotonic and enzyme-free aqueous formulations ... agents in either Ca2+- and Mg2+-free ... Ca2+- and Mg2+-free phosphate-buffered saline for ... support substrates and each other for ...
...
... Kit Components , 25 g Blocking Reagent , ... 10 ml T7 Elution Buffer , 0.2 ml ... , 0.2 ml BLT5615 glycerol stock , 1010 ... Negative Control Lysate , 50 l S-protein HRP Conjugate ...
Biology Products: